Clinical Characterization of FGFR ‐Altered Pediatric Low‐Grade Gliomas
Benjamin Posorske, Elizabeth S. Borden, Shea Gallus, Ahmed Gilani et autres
us (code pays fourni par la source)
0 citations
Pediatric Blood & Cancer
Stewart Goldman
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
379Publications signalées
13887Citations signalées
4Affiliations récentes
Les institutions déclarées
Les domaines associés
Glioma Diagnosis and TreatmentNeuroblastoma Research and TreatmentsNeurofibromatosis and Schwannoma CasesBrain Metastases and TreatmentEpigenetics and DNA Methylation
Les publications récentes
QLTI-02. Management of adverse events occurring with MAPK-directed therapies in patients with pediatric low-grade glioma: Recommendations from an expert Delphi consensus initiative
Darren Hargrave, Stewart Goldman, Grant T. Liu, Jennifer T. Huang et autres
gb, us, nl, cz, ca (code pays fourni par la source)
0 citations
Neuro-Oncology
Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial
Amy E. Armstrong, Coretta Thomas Robinson, Jeffrey C. Allen, Yongzheng He et autres
us (code pays fourni par la source)
0 citations
Carolina Digital Repository (University of North Carolina at Chapel Hill)
Data from Measles Oncolytic Virus as an Immunotherapy for Recurrent/Refractory Pediatric Medulloblastoma and Atypical Teratoid/Rhabdoid Tumor: Results from PNOC005
Bohyeon Yu, Cassie Kline, Owen Hoare, Jangham Jung et autres
1 citation
The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science
Sharon Gardner, D. Williams Parsons, Adam Resnick, James M. Johnston et autres
us (code pays fourni par la source)
0 citations
Carolina Digital Repository (University of North Carolina at Chapel Hill)
Measles Oncolytic Virus as an Immunotherapy for Recurrent/Refractory Pediatric Medulloblastoma and Atypical Teratoid/Rhabdoid Tumor: Results from PNOC005
Bohyeon Yu, Cassie Kline, Owen Hoare, Jangham Jung et autres
us, ch (code pays fourni par la source)
11 citations
Clinical Cancer Research
A comparative analysis of IDH-mutant glioma in pediatric, young adult, and older adult patients
Mary Jane Lim-Fat, Jennifer Cotter, Mehdi Touat, Jayne Vogelzang et autres
ca, us, fr (code pays fourni par la source)
17 citations
Neuro-Oncology
LGG-37. A PHASE III STUDY COMPARING TWO CARBOPLATIN CONTAINING REGIMENS FOR CHILDREN AND YOUNG ADULTS WITH PREVIOUSLY UNTREATED LOW-GRADE GLIOMA
Alicia Lenen, Angela J. Waanders, Latifa A. Bazzi, Hui Zhang et autres
us (code pays fourni par la source)
1 citation
Neuro-Oncology
DIPG-91. CLINICAL, RADIOGRAPHIC, HISTOPATHOLOGIC, AND MOLECULAR CHARACTERISTICS OF LONG-TERM SURVIVORS OF DIFFUSE INTRINSIC PONTINE GLIOMA-AN UPDATE FROM THE INTERNATIONAL AND EUROPEAN SOCIETY FOR PEDIATRIC ONCOLOGY DIPG REGISTRIES (IDIPGR/SIOPE-DIPGR)
Natasha Pillay‐Smiley, Gunther Nussbaumer, Carin Damen-Corbijn, Joshua Baugh et autres
us, at, nl, fr, ca, it, de, gb (code pays fourni par la source)
0 citations
Neuro-Oncology
TRLS-11. PNOC005: ONCOLYTIC MEASLES VIRUS FOR THE TREATMENT OF CHILDREN AND YOUNG ADULTS WITH RECURRENT MEDULLOBLASTOMA OR ATYPICAL TERATOID RHABDOID TUMOR
Cassie Kline, Bohyeon Yu, Truman Knowles, Aeesha Ranavaya et autres
us, ch (code pays fourni par la source)
3 citations
Neuro-Oncology
LGG-48. CLINICAL CHARACTERIZATION OF FGFR-ALTERED, PEDIATRIC LOW-GRADE GLIOMAS
Benjamin Posorske, Nishant Tiwari, Lisa Keller, Kathleen Dorris et autres
us (code pays fourni par la source)
0 citations
Neuro-Oncology
Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 Trial
Daphne A. Haas‐Kogan, Mariam Aboian, Jane E. Minturn, Sarah Leary et autres
us, de, no, ch (code pays fourni par la source)
27 citations
Journal of Clinical Oncology
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.